
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Umeboshi plum (Prunus mume) contains citric acid, polyphenols, and mumefural that modulate cellular pathways including EGF receptor transactivation and ERK signaling for cardiovascular and anti-inflammatory effects. The fermented fruit demonstrates antimicrobial activity against S. aureus and E. coli through proanthocyanidin-mediated cell membrane disruption.

Reported Benefits (Provisional)
Origin & History

Umeboshi Plum (Prunus mume) is a traditional fermented fruit originating from Japan, with a long history of cultivation and use across China and Korea. It thrives in temperate climates. This highly prized plum is revered in functional nutrition for its potent digestive, detoxifying, and immune-supporting properties.
Research Narrative (Provisional)
Scientific studies investigate the gastrointestinal, hepatoprotective, and immunomodulatory effects of Umeboshi Plum. Research highlights its role in supporting digestive health, liver detoxification, and cardiovascular resilience, validating its traditional applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Minerals: Potassium, Calcium, Magnesium - Phytochemicals/Bioactives: Citric Acid, Malic Acid, Polyphenols, Flavonoids, Dietary Fiber, Probiotic-Friendly Compounds
Reported Mechanism (Provisional)
Umeboshi's bainiku-ekisu extract inhibits H2O2-induced and AngII-induced EGF receptor transactivation while partially suppressing downstream ERK activation, reducing vascular protein synthesis. Five anti-allergic compounds (vanillic acid, syringic acid, p-hydroxybenzoic acid, coumaric acid, and lycopersiconolide) nearly completely block intracellular Ca2+ mobilization and IgE-mediated mast cell degranulation. Proanthocyanidins damage bacterial cell walls at MIC concentrations of 1.563 mg/mL for S. aureus and 3.125 mg/mL for E. coli.
Clinical Narrative (Provisional)
Current evidence for umeboshi plum derives primarily from in vitro and in vivo studies rather than human clinical trials. Laboratory studies demonstrate specific molecular mechanisms including complete inhibition of AngII-induced EGF receptor activation and mast cell degranulation suppression. Limited epidemiological data suggests reduced allergic symptom risk in women consuming ume, but quantified clinical trial outcomes are not available. The evidence base requires human intervention studies to validate therapeutic applications and establish effective dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







